Table 1.
Correlation between clinicopathological features and BRINP3 expression.
| Characteristics | BRINP3 protein expression | P value | |
|---|---|---|---|
| Low expression n(%) | High expression n(%) | ||
| Age | 0.805 | ||
| <20 | 25 (75.8%) | 42 (71.2%) | |
| ≥20 | 8 (24.2%) | 17 (28.8%) | |
| Gender | 0.028 | ||
| Female | 19 (57.6%) | 20 (33.9%) | |
| Male | 14 (42.4%) | 39 (66.1%) | |
| Tumor size | 0.13 | ||
| <5 | 3 (9.1%) | 1 (1.7%) | |
| ≥5 | 30 (90.9%) | 58 (98.3%) | |
| Tumor position | 0.975 | ||
| Femur | 15 (45.5%) | 30 (50.8%) | |
| Tibia | 8 (24.2%) | 13 (22.0%) | |
| Humerus | 4 (12.1%) | 7 (11.9%) | |
| Fibulars | 2 (6.1%) | 2 (3.4%) | |
| Irregular bone | 4 (12.1%) | 7 (11.9%) | |
| Histologic grade | <0.001 | ||
| Low grade | 24 (72.7%) | 14 (23.7%) | |
| High grade | 9 (27.3%) | 45 (76.3%) | |
| Metastasis | 0.081 | ||
| Present | 20 (60.6%) | 23 (39.0%) | |
| Absent | 9 (27.3%) | 30 (50.8%) | |
| Unknown | 4 (12.1%) | 6 (10.2%) | |
| Recurrence | <0.001 | ||
| Positive | 4 (12.1%) | 51 (86.4%) | |
| Negative | 26 (78.8%) | 5 (8.5%) | |
| Unknown | 3 (9.1%) | 3 (5.1%) | |